What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

During his 36-year career at Fred Hutch Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He co-founded the field of paleovirology and ...

The Pacific Northwest (PNW) Prostate Cancer SPORE aims to focus on finding molecular and other factors associated with the risk of prostate cancer recurrence and progression as well as its response – ...

Thanks to our generous supporters, Fred Hutch is redefining cancer and infectious disease for the next generation. Join us as we look beyond what’s possible today toward a new era of world-changing ...

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.

Blood clots can be a common – and even deadly – side effect of both cancer and its treatment. Fred Hutch's Dr. Gary Lyman, an expert in blood clots (also known as thrombi) is helping set national ...